Roche: APHINITY Trial Shows Significant Improvement Of Overall Survival
13/5 07:26
(RTTNews) - Roche (RHHBY), the Breast International Group, Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation, announced statistically significant final overall survival results from the phase III APHINITY study in people with HER2-positive early-s...